The emergence of Retatrutide ZPHC, at a dosage of 120mg, is sparking considerable interest within the weight loss community. This innovative dual GIP and GLP-1 receptor medication suggests to offer impressive improvements in fat loss compared to current therapies. Initial research data have demon